Certified by Founder Lodge
MPM BioImpact
United States - Boston, Massachusetts
INVESTOR
1 Disclosed Funding Rounds $80,000,000
6 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
MPM BioImpact is a world-leading biotechnology investment firm with nearly three decades of experience creating and investing in companies that seek to translate scientific innovations into c
| Company | Date | Round | Raised |
|---|---|---|---|
 Crossbow Therapeutics, Inc |
July, 12 ,2023 | Series A | $80,000,000 |
 Arialys Therapeutics, Inc. |
September, 13 ,2023 | Seed | $58,000,000 |
 ReCode Therapeutics |
September, 20 ,2023 | Series B | $50,000,000 |
 AstronauTx |
October, 09 ,2023 | Series A | $58,462,000 |
 NextPoint Therapeutics, Inc. |
February, 15 ,2024 | Series B | $42,500,000 |
 Umoja Biopharma |
January, 21 ,2025 | Series C | $100,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Sizable Energy | $8,000,000 | (Oct 24, 2025)
Sumble | $38,500,000 | (Oct 24, 2025)
Syntracts | $5,300,000 | (Oct 24, 2025)
Cybrid | $10,000,000 | (Oct 24, 2025)
Elevara Medicines | $70,000,000 | (Oct 24, 2025)
